von Hippel–Lindau tumor suppressor: not only HIF's executioner
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (4) , 146-149
- https://doi.org/10.1016/j.molmed.2004.02.004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The Hsp70 and TRiC/CCT Chaperone Systems Cooperate In Vivo To Assemble the Von Hippel-Lindau Tumor Suppressor ComplexMolecular and Cellular Biology, 2003
- Disruption of oxygen homeostasis underlies congenital Chuvash polycythemiaNature Genetics, 2002
- Molecular basis of the VHL hereditary cancer syndromeNature Reviews Cancer, 2002
- Structural basis for the recognition of hydroxyproline in HIF-1α by pVHLNature, 2002
- Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase ActivityMolecular and Cellular Biology, 2002
- An intact NEDD8 pathway is required for Cullin‐dependent ubiquitylation in mammalian cellsEMBO Reports, 2002
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinJournal of Biological Chemistry, 2000
- Formation of the VHL–Elongin BC Tumor Suppressor Complex Is Mediated by the Chaperonin TRiCMolecular Cell, 1999
- Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor FunctionScience, 1999
- Inhibition of Transcription Elongation by the VHL Tumor Suppressor ProteinScience, 1995